Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.
about
Anticardiolipin and anti-beta2glycoprotein-I antibodies in patients with systemic lupus erythematosus: comparison between Colombians and Spaniards.Anti-cardiolipin and anti-beta2 glycoprotein I antibodies in Indian patients with systemic lupus erythematosus: association with the presence of seizures.Association of beta2-glycoprotein I IgG and IgM antibodies with thrombosis and thrombocytopenia.Autoantibodies associated with rheumatic diseases.Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I.Prevalence and isotype distribution of antiphospholipid antibodies in Chilean patients with systemic lupus erythematosus (SLE).True anti-anionic phospholipid immunoglobulin M antibodies can exert lupus anticoagulant activity.Correlation between beta 2-glycoprotein antibodies and antiphospholipid antibodies in patients with reproductive failure.Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes.Anticardiolipin and anti-beta(2) glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits.Anti-beta2-glycoprotein I ELISA: methodology, determination of cut-off values in 434 healthy Caucasians and evaluation of monoclonal antibodies as possible international standards.Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus.Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis
P2860
Q33328447-6C01CA13-F7BB-4A0B-AA65-A4D883D84E98Q33336296-FE835FBC-4A70-4869-B4A4-38FB90350119Q33338788-8AE6E0D8-11FD-43C4-92BC-63154CB1C370Q34249566-F24B97F7-F33F-445B-B937-64655C107AF1Q36222874-F99238EF-FF52-4A3A-B916-943BC67185F2Q43677862-9401A8D0-0DE2-4499-8031-8E6B9769B9C0Q43910570-4EB7A561-4A80-4B54-9014-066C932E33BBQ44286410-2060D826-58FD-4E84-9E57-AC5712105AADQ47685798-AC5C4496-C2CF-4D9C-AFEA-B01902AFAF47Q53325327-18641314-7AAF-4421-BD0F-D84F9B80AEE3Q53331016-6C373187-0B22-4D4C-9807-0D6FF16144DAQ53947913-69793D35-5377-442D-A266-0E080DC65BDBQ57602063-6D13CED3-049E-4AA8-A05D-992FBCFC3554
P2860
Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.
@ast
Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.
@en
type
label
Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.
@ast
Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.
@en
prefLabel
Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.
@ast
Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.
@en
P2093
P50
P356
P1476
Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome
@en
P2093
P304
P356
10.1093/RHEUMATOLOGY/36.1.113
P577
1997-01-01T00:00:00Z